BigHat Biosciences secures $75M Series C to advance AI-designed protein therapeutics. Total funding reaches $223M. Discover ...
FDA approves Welireg and Lenvima combination for advanced renal cell carcinoma. Learn about this breakthrough treatment for ...
XtalPi files FDA IND application for KQTD-126, a gut-restricted pan-TRK inhibitor for chronic intestinal pain. First-in-class ...
Addex Therapeutics regains full global rights to GABAB PAM portfolio from Indivior. Collaboration termination follows ...
FDA approves Elevar's Lyrfigtu (lirafugratinib) for previously treated cholangiocarcinoma with FGFR2 fusion. Learn about this breakthrough cancer treatment.
Earendil Labs partners with Genentech for AI-designed bispecific antibodies in oncology. $1.5B+ deal includes $55M upfront payment and milestone targets.
Arcturus Therapeutics unveils LUNAR 2.0 platform with 38-fold potency increase for OTC deficiency treatment. Phase II interim data released. Read more.
Astellas doses first patient in Phase III setidegrasib trial for KRAS G12D lung cancer. First-in-class treatment with no approved competitors. Read more.
Eli Lilly partners with Beijing-based InnoCare Pharma in $3.25B strategic collaboration for oncology and autoimmune disease ...
Variant Bio expands collaboration with Boehringer Ingelheim into cardiovascular disease with USD 250M in potential payments. Read the latest biotech news.
Anthropic's autonomous AI agents identified a previously unknown enzyme system (ART) in bacteriophages, analyzing 1.94 billion protein clusters. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results